Exact Mass: 377.0626

Glucosisymbrin

C10H19NO10S2 (377.045)

KG-501

C17H13ClNO5P (377.022)

2-Hydroxypropyl glucosinolate

C10H19NO10S2 (377.045)

2-Hydroxypropyl glucosinolate is found in brassicas. 2-Hydroxypropyl glucosinolate is present in horseradish (Armoracia lapathifolia). Present in horseradish (Armoracia lapathifolia). 2-Hydroxypropyl glucosinolate is found in horseradish and brassicas.

4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole

C21H16FN3OS (377.0998)

N-Hbgd

C15H23NO6S2 (377.0967)

S-Pyruvylglutathione

C13H19N3O8S (377.0893)

3-Hydroxypropyl glucosinolate

C10H19NO10S2 (377.045)

RIT-D-2214

C13H19N3O6S2 (377.0715)

7-Methyl-XMP

C11H16N5O8P (377.0736)

Maybridge1_001336

C12H10F3N5O2S2 (377.0228)

Maybridge1_000863

C21H16FN3OS (377.0998)

7-Methylguanosine 5-phosphate

C11H16N5O8P (377.0736)

O1-(2-acetylamino-[1]naphthyl)-beta-D-glucopyranuronic acid|O1-(2-Acetylamino-[1]naphthyl)-beta-D-glucopyranuronsaeure

C18H19NO8 (377.1111)

4-methoxyfuro[2,3-b]quinolin-7-yl beta-D-mannopyranoside|dictamnine-7-beta-D-mannopyranoside

C18H19NO8 (377.1111)

S-methyl-5-thio-[3]adenylic acid|Thiomethyladenosin

C11H16N5O6PS (377.0559)

Xenocladoniamide A

C20H12ClN3O3 (377.0567)

O1-(6-acetylamino-[2]naphthyl)-beta-D-glucopyranuronic acid|O1-(6-Acetylamino-[2]naphthyl)-beta-D-glucopyranuronsaeure

C18H19NO8 (377.1111)

Oxychelirubine

C21H15NO6 (377.0899)

Eudistomidin F

C16H16BrN3OS (377.0197)

Sparoxomycin A1

C13H19N3O6S2 (377.0715)

7-chloro-(2R)-2-O-beta-D-glucopyranosyl-4-hydroxy-2H-1,4-benzoxazin-3(4H)-one|7-Cl-DIBOA-Glc

C14H16ClNO9 (377.0514)

Asp Asp Glu

C13H19N3O10 (377.107)

Glu Asp Asp

C13H19N3O10 (377.107)

SB 203580

C21H16FN3OS (377.0998)

D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents C308 - Immunotherapeutic Agent D004791 - Enzyme Inhibitors

12-Hydroxychelirubine

C21H15NO6 (377.0899)

3-Hydroxypropyl-Glucosinolate

C10H19NO10S2 (377.045)

Acquisition and generation of the data is financially supported by the Max-Planck-Society

FR167356

C19H17Cl2NO3 (377.0585)

CONFIDENCE standard compound; INTERNAL_ID 245; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8799; ORIGINAL_PRECURSOR_SCAN_NO 8796 CONFIDENCE standard compound; INTERNAL_ID 245; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8818; ORIGINAL_PRECURSOR_SCAN_NO 8815 CONFIDENCE standard compound; INTERNAL_ID 245; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8849; ORIGINAL_PRECURSOR_SCAN_NO 8845 CONFIDENCE standard compound; INTERNAL_ID 245; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8855; ORIGINAL_PRECURSOR_SCAN_NO 8850 CONFIDENCE standard compound; INTERNAL_ID 245; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8828; ORIGINAL_PRECURSOR_SCAN_NO 8825 CONFIDENCE standard compound; INTERNAL_ID 245; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8869; ORIGINAL_PRECURSOR_SCAN_NO 8867

Asp Glu Asp

C13H19N3O10 (377.107)

S-Pyruvylglutathione

C13H19N3O8S (377.0893)

Asn-His-OH

C15H15N5O7 (377.0971)

2-Hydroxypropyl glucosinolate

C10H19NO10S2 (377.045)

4-(2-Chlorophenyl)-5-methoxycabonyl-3-ethoxycarbonyl-6-methylpicolinic acid

C18H16ClNO6 (377.0666)

Omeprazole Sulfone N-Oxide

C17H19N3O5S (377.1045)

Fenthiaprop

C18H16ClNO4S (377.0489)

(4aR,8aR)-1-Bromo-3-methoxy-6-oxo-5,6,9,10-tetrahydro-4aH-[1]benz ofuro[3a,3,2-ef][2]benzazepine-11(12H)-carbaldehyde

C17H16BrNO4 (377.0263)

N-BOC-2-BROMO-5-BENZYLOXYANILINE

C18H20BrNO3 (377.0626)

Disperse Orange 29

C19H15N5O4 (377.1124)

7-(4-BROMO-2,6-DIMETHYLPHENYL)-4-CHLORO-2,5,6-TRIMETHYL-7H-PYRROLO[2,3-D]PYRIMIDINE

C17H17BrClN3 (377.0294)

5-nitrofluorescein

C20H11NO7 (377.0535)

Scopine Di(2-thienyl) Glycolate

C18H19NO4S2 (377.0755)

Benzenesulfonic acid,4-hydroxy-5-(2-hydroxy-4-methoxybenzoyl)-2-methoxy-, sodium salt (1:1)

C15H14NaO8S+ (377.0307)

2-Carboxy-5-fluoro-1-[(1-naphthalenyl)methyl]-1H-indole-3-acetic acid

C22H16FNO4 (377.1063)

UNII:S1199Y391N

C14H15N7O2S2 (377.0729)

2-BROMO-6-IODO-3-METHOXYPYRIDINE

C22H16FNO4 (377.1063)

tert-Butyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

C19H24BrNO2 (377.099)

ethyl 2-[4-[(6-chlorobenzothiazol-2-yl)oxy]phenoxy]propionate

C18H16ClNO4S (377.0489)

2H-Pyrrol-2-one, 4-acetyl-1-(4-bromophenyl)-5-cyclohexyl-1,5-dihydro-3-hydroxy-

C18H20BrNO3 (377.0626)

Ronifibrate

C19H20ClNO5 (377.103)

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates

4,4,4-Nitrilotribenzoic acid

C21H15NO6 (377.0899)

ERRα antagonist-1

C21H19N3S2 (377.102)

1-PIPERIDINECARBOXYLIC ACID 4-(4-IODO-1H-PYRAZOL-1YL)-,1-1-DIMETHYLETHYLESTER

C13H20IN3O2 (377.06)

Robenidine-d8 HCl

C15H6Cl3D8N5 (377.0817)

Methyl 2-BroMo-3-(4-(2-(3-Methylpyridin-2-yl)ethoxy)phenyl)propanoate

C18H20BrNO3 (377.0626)

5-Bromodescyano Citalopram

C19H21BrFNO (377.079)

4-Nitrofluorescein

C20H11NO7 (377.0535)

4-[[2-methoxy-4-[(4-nitrophenyl)azo]phenyl]azo]phenol

C19H15N5O4 (377.1124)

Pyridine, 4-(4-(4-fluorophenyl)-2-(5-((R)-methylsulfinyl)phenyl)-1H-imidazol-4-yl)-

C21H16FN3OS (377.0998)

Glufanide disodium

C16H17N3Na2O5 (377.0964)

D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D020011 - Protective Agents > D000931 - Antidotes C308 - Immunotherapeutic Agent D007155 - Immunologic Factors

Acridine half-mustard

C19H21Cl2N3O (377.1062)

D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D009676 - Noxae > D009153 - Mutagens

COX-2 Inhibitor I

C18H16ClNO4S (377.0489)

2-(4-morpholinyl)-N-[(2-nitrophenyl)-oxomethyl]-4-thiazolecarbohydrazide

C15H15N5O5S (377.0794)

2-O-Methylguanosine 5-monophosphate

C11H16N5O8P (377.0736)

1-(4-Bromo-2,5-dimethoxyphenyl)sulfonylazepane

C14H20BrNO4S (377.0296)

1-Methylguanosine 5-(dihydrogen phosphate)

C11H16N5O8P (377.0736)

Ethyl 2-amino-4-(4-chlorophenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carboxylate

C18H16ClNO6 (377.0666)

N-[3-chloro-4-(4-morpholinyl)phenyl]-1,1-dioxo-1,2-benzothiazol-3-amine

C17H16ClN3O3S (377.0601)

N-(1,3-benzodioxol-5-yl)-3-methyl-6-phenyl-2-imidazo[2,1-b]thiazolecarboxamide

C20H15N3O3S (377.0834)

2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid

C17H10F3N3O2S (377.0446)

[2-Amino-6-(2,6-difluoro-benzoyl)-imidazo[1,2-A]pyridin-3-YL]-phenyl-methanone

C21H13F2N3O2 (377.0976)

7,8-Dihydro-8-oxo-guanosine 5-phosphate

C10H12N5O9P-2 (377.0373)

N2-hydroxyguanosine 5-monophosphate

C10H12N5O9P-2 (377.0373)

4,5-Dihydrofarnesyl diphosphate

C15H23O7P2-3 (377.0919)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-4-hydroxy-N-sulfooxybutanimidothioate

C10H19NO10S2 (377.045)

S-lactoylgluta-thione

C13H19N3O8S (377.0893)

Glu-Asp-Asp

C13H19N3O10 (377.107)

4-[(3,5-Dichloro-2-hydroxyphenyl)methylamino]-1,5-dimethyl-2-phenyl-3-pyrazolone

C18H17Cl2N3O2 (377.0698)

N-[[4-(dimethylsulfamoyl)anilino]-sulfanylidenemethyl]-2-phenylacetamide

C17H19N3O3S2 (377.0868)

1-[[(E)-(3-bromo-6-keto-cyclohexa-2,4-dien-1-ylidene)methyl]amino]-3-phenethyl-thiourea

C16H16BrN3OS (377.0197)

N(7)-methylguanosine 5-phosphate

C11H16N5O8P (377.0736)

4-benzyl-N-(3,5-dichlorophenyl)-1,4-diazepane-1-carboxamide

C19H21Cl2N3O (377.1062)

4-bromo-N-(2-phenazinyl)benzamide

C19H12BrN3O (377.0164)

1,3-Benzodioxol-5-yl 4-(diethylsulfamoyl)benzoate

C18H19NO6S (377.0933)

N(2)-methylguanosine 5-monophosphate

C11H16N5O8P (377.0736)

8-chloro-N-(4-fluorophenyl)-2-(2-pyridinyl)-4-quinolinecarboxamide

C21H13ClFN3O (377.0731)

N-(7-bromo-3,4-dihydro-2H-1,5-benzodioxepin-8-yl)-3-methoxybenzamide

C17H16BrNO4 (377.0263)

3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide

C20H15N3O5 (377.1012)

N-ethyl-8-methyl-4-oxo-N-(phenylmethyl)-2-thieno[3,2-c][1]benzopyrancarboxamide

C22H19NO3S (377.1086)

2-[[2-Oxo-2-[4-[5-(trifluoromethyl)-2-pyridinyl]-1,4-diazepan-1-yl]ethyl]thio]acetic acid

C15H18F3N3O3S (377.1021)

N-[(E)-[4-(2,3-Dichloroanilino)-4-oxobutan-2-ylidene]amino]-2-methylbenzamide

C18H17Cl2N3O2 (377.0698)

1-[4-[4-[(5-Bromo-2-furanyl)methylamino]phenyl]-1-piperazinyl]ethanone

C17H20BrN3O2 (377.0739)

Asp-Glu-Asp

C13H19N3O10 (377.107)

Asp-Asp-Glu

C13H19N3O10 (377.107)

(5E)-5-[[1-(4-chloro-2-fluorophenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-3-methyl-2-methylimino-1,3-thiazolidin-4-one

C18H17ClFN3OS (377.0765)

2-[(3,4,8,9,10-Pentahydroxy-6-oxobenzo[c]chromene-1-carbonyl)amino]acetic acid

C16H11NO10 (377.0383)

Adaptaquin

C21H16ClN3O2 (377.0931)

Adaptaquin is an inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 (HIF-PHD2), with an IC50 of 2 μM. Adaptaquin can inhibit lipid peroxidation and maintain mitochondrial function[1][2].

(2e)-3-(2,4-dihydroxy-6-methylpyrimidin-5-yl)-n-[(2s)-1-hydroxy-3-[(r)-(r)-methanesulfinylmethanesulfinyl]propan-2-yl]prop-2-enimidic acid

C13H19N3O6S2 (377.0715)

7-cl-diboa-glc

C14H16ClNO9 (377.0514)

{"Ingredient_id": "HBIN013138","Ingredient_name": "7-cl-diboa-glc","Alias": "NA","Ingredient_formula": "C14H16ClNO9","Ingredient_Smile": "C1=CC2=C(C=C1Cl)OC(C(=O)N2O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3815","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(4r)-11-bromo-3-methyl-4-[(methylsulfanyl)methyl]-1,3,6-triazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-12-ol

C16H16BrN3OS (377.0197)

n-(2-hydroxy-5-{[8-(hydroxymethyl)-3-oxophenoxazin-2-yl]amino}phenyl)carboximidic acid

C20H15N3O5 (377.1012)

(2e)-3-(2,4-dihydroxy-6-methylpyrimidin-5-yl)-n-[(2s)-1-hydroxy-3-[(r)-(s)-methanesulfinylmethanesulfinyl]propan-2-yl]prop-2-enimidic acid

C13H19N3O6S2 (377.0715)

2-(4-{6-chloro-3h-pyrrolo[2,3-c]quinolin-4-yl}-1,3-thiazol-2-yl)phenol

C20H12ClN3OS (377.039)

7-chloro-4-hydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h-1,4-benzoxazin-3-one

C14H16ClNO9 (377.0514)

2-(hydroxymethyl)-6-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)oxane-3,4,5-triol

C18H19NO8 (377.1111)

(2r,3s,4s,5s,6s)-2-(hydroxymethyl)-6-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)oxane-3,4,5-triol

C18H19NO8 (377.1111)

(2s,5r,6r)-6-[(2-{[(2s)-2-amino-2-carboxyethyl]sulfanyl}-1-hydroxyethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C13H19N3O6S2 (377.0715)

2-(4-{1-chloro-3h-pyrrolo[2,3-c]quinolin-4-yl}-1,3-thiazol-2-yl)phenol

C20H12ClN3OS (377.039)

11-bromo-3-methyl-4-[(methylsulfanyl)methyl]-1,3,6-triazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-12-ol

C16H16BrN3OS (377.0197)

6-({2-[(2-amino-2-carboxyethyl)sulfanyl]-1-hydroxyethylidene}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C13H19N3O6S2 (377.0715)

4-[5-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1h-imidazol-4-yl]pyridine

C21H16FN3OS (377.0998)

(2r)-7-chloro-4-hydroxy-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h-1,4-benzoxazin-3-one

C14H16ClNO9 (377.0514)

(2e)-3-(2,4-dihydroxy-6-methylpyrimidin-5-yl)-n-(1-hydroxy-3-methanesulfinylmethanesulfinylpropan-2-yl)prop-2-enimidic acid

C13H19N3O6S2 (377.0715)